8852
-
Journal of Inflammation Research
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Emerging therapies for treatment of multiple sclerosis
Review
(2689) Views (895) Full article downloads
Authors: John R Corboy, Augusto A Miravalle
Published Date July 2010
Volume 2010:3 Pages 53 - 59
DOI: http://dx.doi.org/10.2147/JIR.S6558
John R Corboy, Augusto A MiravalleRocky Mountain Multiple Sclerosis Center, Anschutz Medical Campus, University of Colorado Denver, Aurora, Colorado, USA
Abstract: In the last decade, a new armamentarium of immune-based therapies have been developed and tested in patients with multiple sclerosis. Some of these therapies are showing a high level of efficacy, with an acceptable adverse effect profile. Because present therapies have significant limitations in slowing disease progression, require injections, are sometimes associated with significant side effects of immunosuppression, and do little to reverse disability, identifying more effective treatments is an important goal for clinical research in multiple sclerosis. However, in order to improve our current approach to disease-modifying therapies, it is imperative to promote the development of individualized therapy strategies.
Keywords: multiple sclerosis, lymphocyte-targeted therapy, immune sequestration, non-specific immune modulation
Readers of this article also read:
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
Potential of anti-inflammatory treatment for cystic fibrosis lung disease
Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets
The effect of smoking on the symptoms and progression of multiple sclerosis: a review
The role of the NLRP3 inflammasome in gout
Erratum
Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
Editorial
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
Potential of anti-inflammatory treatment for cystic fibrosis lung disease
Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets
The effect of smoking on the symptoms and progression of multiple sclerosis: a review
The role of the NLRP3 inflammasome in gout
Erratum
Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
Editorial
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Local anesthetic failure associated with inflammation: verification of the acidosis mechanism and the hypothetic participation of inflammatory peroxynitrite
- Inflammatory mediators: Parallels between cancer biology and stem cell therapy
- Inflammatory mechanisms in the lung
- Rotator cuff troublemakers: pitfalls of MRI and ultrasound
